A detailed history of Cornerstone Planning Group LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 13 shares of CTLT stock, worth $775. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13
Previous 13 -0.0%
Holding current value
$775
Previous $769,000 0.78%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$53.58 - $57.02 $696 - $741
13 New
13 $769,000
Q3 2023

Nov 08, 2023

BUY
$44.2 - $50.2 $1,768 - $2,008
40 Added 23.53%
210 $9.56 Million
Q2 2023

Aug 15, 2023

BUY
$31.86 - $67.26 $2,835 - $5,986
89 Added 109.88%
170 $7.37 Million
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $3,352 - $6,561
81 New
81 $3.99 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.7B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Cornerstone Planning Group LLC Portfolio

Follow Cornerstone Planning Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Planning Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Planning Group LLC with notifications on news.